Related Experiment Videos
Enzyme inhibitory constituents from Duranta repens
Itrat Anis1, Saeed Ahmed, Abdul Malik
1International Center of Chemical Sciences, HEJ Research Institute of Chemistry, University of Karachi, Pakistan.
Chemical & Pharmaceutical Bulletin
|April 20, 2002
Summary
Researchers isolated novel isoprenylated flavonoids and acetophenone derivatives from Duranta repens. Several compounds demonstrated inhibitory activity against prolyl endopeptidase and thrombin, highlighting potential therapeutic applications.
Area of Science:
- Phytochemistry
- Natural Product Chemistry
- Pharmacology
Background:
- Duranta repens is a plant species known for its diverse chemical constituents.
- Flavonoids and acetophenone derivatives are classes of natural products with significant biological activities.
- Investigating the chemical composition of medicinal plants can lead to the discovery of novel bioactive compounds.
Purpose of the Study:
- To isolate and characterize new isoprenylated flavonoids and acetophenone derivatives from Duranta repens.
- To evaluate the biological activities of the isolated compounds, specifically their inhibitory effects on prolyl endopeptidase and thrombin.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation employing various spectroscopic methods, including 1H- and 13C-NMR, IR, UV, MS, and 2D-NMR experiments.
- In vitro assays to assess inhibitory activity against prolyl endopeptidase and thrombin.
Main Results:
- Three new compounds were isolated: isoprenylated flavonoids 5,7-dihydroxy-3'-(2-hydroxy-3-methyl-3-butenyl)-3,6,4'-trimethoxyflavone (1) and 3,7-dihydroxy-3'-(2-hydroxy-3-methyl-3-butenyl)-5,6,4'-trimethoxyflavone (2), and an isoprenylated acetophenone derivative (3).
- Eight known compounds were also identified, with compounds 6-8 being isolated from Duranta repens for the first time.
- Compounds 1-5 exhibited inhibitory activity against prolyl endopeptidase.
- Compounds 4 and 5 also showed activity against thrombin.
Conclusions:
- The study successfully identified novel isoprenylated flavonoids and acetophenone derivatives from Duranta repens.
- The isolated compounds, particularly 1-5, demonstrate potential as inhibitors of prolyl endopeptidase.
- Compounds 4 and 5 show promise as inhibitors of thrombin, suggesting potential therapeutic applications in relevant diseases.